Skip to main content
All lobbying clients

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Lobbying client · District of Columbia · filed 2025 to 2026

Healthcare association

$24,382,276 Reported spend
38 Filings counted
6 Outside firms hired
69 Bills named

Spend is reported income plus in-house expenses across 38 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 7 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 7

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings top 30 of 69
  • H.R. 2214
    DRUG Act
    17 filings
  • S. 927
    Protecting Pharmacies in Medicaid Act
    14 filings
  • S. 864
    HELP Copays Act
    10 filings
  • H.R. 4317
    PBM Reform Act of 2025
    9 filings
  • S. 1967
    PROTECT Act of 2025
    7 filings
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
    7 filings
  • S. 882
    Patients Before Middlemen Act
    7 filings
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
    6 filings
  • S. 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • S. 1095
    Stop STALLING Act
    6 filings
  • S. 3822
    Break Up Big Medicine Act
    6 filings
  • S. 1414
    Expedited Access to Biosimilars Act
    5 filings
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    4 filings
  • H.R. 4409
    Fair Pharmacies for Federal Employees Act of 2025
    4 filings
  • H.R. 5582
    Patients Deserve Price Tags Act
    4 filings
  • H.R. 6609
    Pharmacists Fight Back in Medicare and Medicaid Act
    4 filings
  • H.R. 6610
    Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
    4 filings
  • S. 2355
    Patients Deserve Price Tags Act
    4 filings
  • S. 3345
    PBM Price Transparency and Accountability Act
    4 filings
  • H.R. 1
    One Big Beautiful Bill Act
    3 filings
  • H.R. 1244
    Reducing Drug Prices for Seniors Act
    3 filings
  • H.R. 2041
    Hidden Fee Disclosure Act of 2025
    3 filings
  • H.R. 2450
    Prescription Drug Transparency and Affordability Act
    3 filings
  • H.R. 3269
    ETHIC Act
    3 filings
  • H.R. 4570
    Interagency Patent Coordination and Improvement Act of 2025
    3 filings
  • H.R. 6837
    To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are con…
    3 filings
  • H.R. 7148
    Consolidated Appropriations Act, 2026
    3 filings
  • H.R. 7871
    MVP Act
    3 filings
  • H.R. 7895
    PBM Kickback Prohibition Act
    3 filings
  • H.R. 8143
    Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.
    3 filings
 Reported by year 2 years
  • 2026 $9,963,034 17 filings
  • 2025 $14,419,242 21 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 8
  • HOUSE OF REPRESENTATIVES 26
  • SENATE 19
  • Health & Human Services, Dept of (HHS) 12
  • Centers For Medicare and Medicaid Services (CMS) 7
  • Executive Office of the President (EOP) 7
  • White House Office 5
  • Labor, Dept of (DOL) 3
  • Small Business Administration (SBA) 3
 Recent filings 40 total
Registration
INDIGO HILL STRATEGIES
4th Quarter 2026 (Oct 1 - Dec 31) · posted Nov 6, 2026
View → Q3 report
EMERGENT STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 21, 2026
View → Q3 terminationNo activity
FORWARD GLOBAL
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View → Q3 report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $3,203,049 expenses · posted Oct 20, 2026
View → Q3 report
RYAN COSTELLO STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 12, 2026
View → Q3 report
THE GIBSON GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 5, 2026
View → Q2 reportNo activity
FORWARD GLOBAL
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 20, 2026
View → Q2 report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $3,282,990 expenses · posted Jul 20, 2026
View → Q2 report
EMERGENT STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 17, 2026
View → Q2 report
THE GIBSON GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 10, 2026
View → Q2 report
RYAN COSTELLO STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · $50,000 income · posted Jul 8, 2026
View → Q1 amendment
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $2,996,995 expenses · posted Apr 21, 2026
View → Q1 reportNo activity
FORWARD GLOBAL
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 20, 2026
View → Q1 report
EMERGENT STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View → Q1 report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION Amended
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $299,699 expenses · posted Apr 20, 2026
View → Q1 report
THE GIBSON GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 9, 2026
View → Q1 report
RYAN COSTELLO STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · $50,000 income · posted Apr 7, 2026
View → Q4 report
EMERGENT STRATEGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View → Q4 report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $3,189,666 expenses · posted Jan 20, 2026
View → Registration amendment
THE GIBSON GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · posted Jan 20, 2026
View →

Showing the 20 most recent of 40 filings. Search the explorer for "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem